Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.
about
Potential of PEGylated Toll-Like Receptor 7 Ligands for Controlling Inflammation and Functional Changes in Mouse Models of Asthma and SilicosisTreatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune systemInduction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 DiabetesSynthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responsesNovel synthetic toll-like receptor 4/MD2 ligands attenuate sterile inflammationAdditive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.Synthesis and characterization of PEGylated toll like receptor 7 ligandsStructural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives.Synthesis and Evaluation of Conjugates of Novel TLR7 Inert Ligands as Self-Adjuvanting Immunopotentiators.A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinomaConjugation of toll-like receptor-7 agonist to gastric cancer antigen MG7-Ag exerts antitumor effects.Mast cell-mediated inhibition of abdominal neutrophil inflammation by a PEGylated TLR7 ligand.Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligandsIntravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitisInnate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand.Directing the immune system with chemical compounds.Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effects.Strategies for designing synthetic immune agonists.Monocyte targeting and activation by cationic liposomes formulated with a TLR7 agonist.Anti-tumor Activity of Toll-Like Receptor 7 Agonists.Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.Covalently coupled immunostimulant heterodimers.6-(4-Amino-2-butyl-imidazoquinolyl)-norleucine: Toll-like receptor 7 and 8 agonist amino acid for self-adjuvanting peptide vaccine.Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.Antibacterial activities of Groebke-Blackburn-Bienaymé-derived imidazo[1,2-a]pyridin-3-aminesFacile syntheses of functionalized toll-like receptor 7 agonistsStructure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands.Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity.High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
P2860
Q28389397-046303D2-BB82-42F9-9B37-9EE565E2C818Q28484146-BBE79104-BB2D-409F-9785-89FE75951C57Q28548359-F484417E-3D18-4A50-961B-7098256E2B13Q30205195-87F7AE14-F1CD-49EE-B79C-FD940131A005Q33944008-78AA150E-213D-4757-A40A-932C37CFA7BFQ34672618-27E7703B-B673-4937-BF89-2F720F3D26FFQ34714205-CBF0EFC8-AFCC-4D00-91B3-C1217B3AA895Q35170105-7C3E3E66-529E-459D-89AC-AF54E2F1CF69Q35178898-CA9C87A1-0E32-4022-BC50-01EAB8DE5D6CQ35684190-E3494C20-DD8B-478C-91D0-8AB0D3F6F1ACQ35843039-C59AD236-2200-4B15-B7FC-D15380081028Q35947566-39CAED81-5724-4396-BC0C-482073D1F74EQ37043647-3FF31C1C-A505-4C72-ADA9-0A211CDA0FDBQ37423131-6478E8CF-786F-41D6-BBCD-33D1C9C1D9EAQ37426746-2945720A-2F94-43BB-A046-E82DFB458265Q37678709-3F996CC6-0D9D-40F7-9F4D-F22D6B295D13Q38201155-4BD41E4B-2D16-4042-B8D1-8536248A4DF3Q38363654-4BCED85E-13F0-4AED-9A75-0FFAF9B54955Q38841677-F2E93836-7577-4957-A7D4-571AB7382203Q39038777-42333791-1B33-48FA-9686-2A40CAAC8F82Q39377049-49B43970-D2C4-44C0-8D17-DA1DB83D2B31Q40116011-11CF7E26-A599-48D9-B0FD-BF3AA048BA66Q40459615-BA0EECF2-7289-446D-B526-F5A6C822748BQ40911284-4E020EC4-EFD5-48C7-B2A9-C16156199A55Q41886564-711752B7-9E20-42CF-B637-C1AFF51A5AAAQ41981220-8D17ED57-DAC2-483F-9D4E-AF81F50B5801Q42243654-2D547289-04B8-4552-B198-817BA0AAF308Q46091295-14C71BF6-16F8-450C-B8FF-07666FDEE178Q46360938-F417AD2A-7253-4AB1-BAC5-BFF8084AA5CEQ57462700-AF3A6380-233C-45FA-AA93-E3890B611E42
P2860
Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@ast
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@en
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@nl
type
label
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@ast
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@en
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@nl
prefLabel
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@ast
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@en
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@nl
P2093
P2860
P356
P1476
Synthesis and immunological ch ...... ceptor 7 agonistic conjugates.
@en
P2093
Christina C N Wu
Christine S Gray
Crystal S Kuy
Dennis A Carson
Howard B Cottam
Maripat Corr
Michael Chan
Tomoko Hayashi
Wolfgang Wrasidlo
P2860
P304
P356
10.1021/BC900054Q
P577
2009-06-01T00:00:00Z